乙肝疗法查看全文
格隆汇10月20日丨HOOKIPA Pharma(HOOK.US)盘前暴涨近50%报1.79美元。消息面上,HOOKIPA宣布与罗氏公司达成战略合作和许可协议,为KRAS突变癌症开发新型ArenaVirus免疫疗法。罗氏将获得HOOKIPA的HB-700项目许可证,并有权获得第二种未... 网页链接
智通财经APP获悉,Fintel将Kaival Brands Innovations Group (KAVL.US)、MDJM Ltd (MDJH.US)、Weber (WEBR.US)、Blink Charging (BLNK.US)和Hookipa Pharma (HOOK.US)列为本周最佳逼空候选公司。 关于MDJH:“NASDAQ报告的原始空头头寸为... 网页链接
$HOOKIPA制药(HOOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-000850 Size: 5 KB 网页链接
$HOOKIPA制药(HOOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-000851 Size: 5 KB 网页链接
$HOOKIPA制药(HOOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-20-000852 Size: 5 KB 网页链接
$HOOKIPA制药(HOOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-19-075319 Size: 12 KB 网页链接
$HOOKIPA制药(HOOK)$ 内部交易: 2019-12-17,Chief Medical Officer,Matushansky Igor ,卖出,11484普通股, $7.87
$HOOKIPA制药(HOOK)$ 内部交易: 2019-12-17,Chief Medical Officer,Matushansky Igor ,期权,26312普通股, $0.10
$HOOKIPA制药(HOOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-19-074342 Size: 8 KB 网页链接
$HOOKIPA制药(HOOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-19-071850 Size: 5 KB 网页链接
$HOOKIPA制药(HOOK)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001104659-19-065358 Size: 11 KB 网页链接
$HOOKIPA制药(HOOK)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-19-010815 Act: 34 Size: 7 MB 网页链接